Loading...
Kings Global Biotech Limited — Everolimus Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Everolimus · $37.7K export value · DGFT Verified
Kings Global Biotech Limited is the #9 Indian exporter of Everolimus with $37.7K in export value and 4 verified shipments. Kings Global Biotech Limited holds a 0.1% market share in Everolimus exports across 1 countries. The company exports 6 pharmaceutical products worth $144.1K across 3 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $11.6M | 232 | 61.5% |
| MALTA | $2.3M | 45 | 11.9% |
| BRAZIL | $1.4M | 28 | 7.4% |
| GERMANY | $1.4M | 27 | 7.2% |
| SAUDI ARABIA | $550.0K | 11 | 2.9% |
| VENEZUELA | $460.3K | 12 | 2.4% |
| SRI LANKA | $350.0K | 7 | 1.9% |
| PERU | $200.0K | 4 | 1.1% |
| MALAYSIA | $200.0K | 4 | 1.1% |
| KENYA | $104.4K | 66 | 0.6% |
India exports Everolimus to 67 countries. The top destination is UNITED STATES (61.5%), followed by MALTA and BRAZIL.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BRECKENRIDGE PHARMACEUTICAL INC | UNITED STATES | $3.1M | 63 |
| PHARMACARE PREMIUM | MALTA | $2.3M | 45 |
| ASCEND LABORATORIES LLC | UNITED STATES | $1.9M | 37 |
| ASCEND GMBH | GERMANY | $1.4M | 27 |
| ASCEND LABORATORIES,LLC | UNITED STATES | $1.4M |
India exported $17.9M worth of Everolimus through 620 shipments from 87 suppliers to 67 countries, serving 135 buyers globally. Kings Global Biotech Limited contributes $37.7K to this total, accounting for 0.1% of India's Everolimus exports.
Kings Global Biotech Limited's average Everolimus shipment value is $9.4K per consignment, based on 4 shipments totaling $37.7K.
Kings Global Biotech Limited ranks #9 among 87 Indian Everolimus exporters with a 0.1% market share. The top 3 exporters are NATCO PHARMA LIMITED ($11.2M), ALKEM LABORATORIES LIMITED ($4.8M), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($750.0K). Kings Global Biotech Limited processed 4 shipments to 1 destination countries.
What Kings Global Biotech Limited must comply with to export Everolimus to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AEON FORMULATIONS PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
| 8 | R.S. SURGIPHARM PRIVATE LIMITED | $38.4K | 35 | 1 | $1.1K |
| 9 | KINGS GLOBAL BIOTECH LIMITED ★ | $37.7K | 4 | 1 | $9.4K |
| 10 | BRUCK PHARMA PRIVATE LIMITED | $33.7K | 3 | 2 | $11.2K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 91 | 14.7% |
| HYDERABAD AIR | 91 | 14.7% |
| SAHAR AIR | 79 | 12.7% |
| HYDERABAD ACC (INHYD4) | 61 | 9.8% |
| DELHI AIR | 43 | 6.9% |
| NHAVA SHEVA SEA (INNSA1) | 29 | 4.7% |
| ACC SHAMSHABAD AIRPO | 23 | 3.7% |
| Bombay Air | 20 | 3.2% |
Kings Global Biotech Limited exports 6 products worth $144.1K. Beyond Everolimus, top products include Lenvatinib, Olaparib, Vinblastine, Cladribine, Lomustine. View the complete Kings Global Biotech Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Everolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kings Global Biotech Limited's Everolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kings Global Biotech Limited
Full Company Profile →
6 products · $144.1K total trade · 3 categories
| 27 |
| BRECKENRIDGE PHARMACEUTICAL, INC | UNITED STATES | $1.1M | 21 |
| NATCOFARMA DO BRASIL LTDA, | BRAZIL | $550.0K | 11 |
| BRECKENRIDGE PHARMACEUTICALS INC | UNITED STATES | $350.0K | 7 |
| BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $300.0K | 6 |
| BIOCON PHARMA INC | UNITED STATES | $150.0K | 3 |
India's Everolimus is purchased by 135 buyers worldwide. The top buyer is BRECKENRIDGE PHARMACEUTICAL INC (UNITED STATES), followed by PHARMACARE PREMIUM and ASCEND LABORATORIES LLC.
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Kings Global Biotech Limited ranks #9 among 87 Indian Everolimus exporters. Average shipment value of $9.4K compared to the market average of $205.9K. The closest competitors by value are AEON FORMULATIONS PRIVATE LIMITED and R.S. SURGIPHARM PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Kings Global Biotech Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Everolimus. For current shipment-level data, contact TransData Nexus.